Neonatal jaundice
Supplements studied for neonatal jaundice.
Overview
Saccharomyces boulardii (WA 44; low effect size, low evidence, medium trust) has uncertain benefit for neonatal jaundice across two studies. One trial found slightly fewer full-term infants developing jaundice and fewer needing phototherapy; effects in premature or high-risk infants and combined use with light therapy are unclear. Nattokinase (WA 44; low effect size, low evidence, medium trust) has insufficient evidence from one study.
Neither supplement has consistent support for preventing or treating neonatal jaundice. Low ratings reflect the limited and inconclusive trial data available.
See the heatmap and evidence reviews below.
Effect graph
Relevant supplements
Relevant supplements sorted by DEX Score.
Studies
Find individual evidence reviews for supplements sorted by DEX Score.
2 supplements for rated at least stars. All purchase bands. No minimum star filter.
Evidence visualised
Same ratings as above, aggregated so you can see coverage and imbalance.